脑梗死溶栓治疗研究的新进展
来源：岁月联盟
时间：2017-03-19
4.6高血糖：数个研究结果同样验证了治疗前的高血糖与溶栓后出血相关[17，19]，在一项研究中，血糖>11.11mmol/l的患者使用rt-PA后其颅内出血率为25％[19]。而在动脉溶栓的PROACT研究中也得出了同样的结论。因此，有学者提出治疗前血糖>22.22mmol/l也应作为溶栓的禁忌症。
参考文献
[1]Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995; 333: 1581-1587
[2]Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke. 1999; 30: 2043-2052
[3]Saver JL, Gornbein J, Grotta JC, Liebeskind DS, Lutsep HL, Schwamm LH, Scott PA, Starkman S. Numbers needed to treat to benefit to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: Joint outcome table analysis of the ECASS 3 trial. Stroke. 2009; 40: 2433-2437
[4]Hacke W, Albers G, Al-Rawl Y, Bogousslavsky J, Davalos A, Eliasziw M, Fisher M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36(1):66-73
[5]Clark WM, Albers GW for the ATLANTIS Stroke Investigators. The Atlantis rt-PA (Alteplase) Acute Stroke Trial: final results [abstract]. Stroke. 1999;30:234
[6]Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352:1245-1251
[7]Clark WM, Albers GW for the ATLANTIS Stroke Investigators. The Atlantis rt-PA (Alteplase) Acute Stroke Trial: final results [abstract]. Stroke. 1999;30:234
[8]Sandercock P, Hennerici MG, Orgogozo JM, Davis SM, Gorelick PB. Mega trials versus small trials in stroke. In: Fisher M, Bogousslavsky J, eds. Current Review of Cerebrovascular Disease. Boston, Mass: Butterworth-Heinemann; 1999:217-222
[9]Scharf J, Brockmann MA, Daffertshofer M, Diepers M, Neumaier-Probst E, Weiss C, Paschke T, Groden C. Improvement of sensitivity and interrater reliability to detect acute stroke by dynamic perfusion computed tomography and computed tomography angiography. J Comput Assist Tomogr. 2006; 30: 105-110
[10]Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials. Lancet. 2004; 363: 768-774
[11]Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM. Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol. 2002; 51: 28-37
[12]廖晓凌，王伊龙，王拥军等.临床神经病学杂志，1004-1648(2007)04-0245-04
[13]The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-18
[14]Cocho D, Borrell M, Marti-Fabregas J, et al. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 2006;37:996-9
[15]Levy D, Brott T, Haley EC, Jr, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291-7
[16]Haley EC, Jr, Lyden PD, Johnston KC, et al. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 2005;36:1109-10
[17]Derex L, Hermier M, Adeleine P, et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.J Neurol Neurosurg Psychiatry 2005;76:70-5
[18]Sylaja PN, Cote R, Buchan AM, et al. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006;77:826-9
[19]Demchuk AM, Morgenstern LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999;30:34-9
下一篇：他汀类药物的临床应用
